tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

ABBV Stock Latest News

AbbVie’s Real-World Study on Upadacitinib for Atopic Dermatitis: Key Insights for Investors
Company AnnouncementsAbbVie’s Real-World Study on Upadacitinib for Atopic Dermatitis: Key Insights for Investors
11h ago
ABBV
AbbVie’s Venetoclax Study: A New Hope for AML Patients in Greece
PremiumCompany Announcements
AbbVie’s Venetoclax Study: A New Hope for AML Patients in Greece
11h ago
ABBV
AbbVie’s Observational Study on Upadacitinib: A Boost for Adolescent Atopic Dermatitis Treatment
PremiumCompany Announcements
AbbVie’s Observational Study on Upadacitinib: A Boost for Adolescent Atopic Dermatitis Treatment
11h ago
ABBV
AbbVie’s Venetoclax Study: A Closer Look at AML Treatment Advancements
PremiumCompany Announcements
AbbVie’s Venetoclax Study: A Closer Look at AML Treatment Advancements
11h ago
ABBV
AbbVie’s New Study on Ulcerative Colitis: A Potential Game Changer?
PremiumCompany Announcements
AbbVie’s New Study on Ulcerative Colitis: A Potential Game Changer?
11h ago
ABBV
AbbVie’s Phase 3 Study on Atogepant: A Potential Game-Changer for Pediatric Migraine Prevention
PremiumCompany AnnouncementsAbbVie’s Phase 3 Study on Atogepant: A Potential Game-Changer for Pediatric Migraine Prevention
11h ago
ABBV
AbbVie and Genmab’s Epcoritamab Trial: A Potential Game-Changer for B-NHL Treatment
Premium
Company Announcements
AbbVie and Genmab’s Epcoritamab Trial: A Potential Game-Changer for B-NHL Treatment
11h ago
ABBV
GMAB
AbbVie’s Pediatric Ulcerative Colitis Study: A Potential Game-Changer?
Premium
Company Announcements
AbbVie’s Pediatric Ulcerative Colitis Study: A Potential Game-Changer?
11h ago
ABBV
AbbVie’s Promising Phase 2 Study on ADPKD Treatment: A Closer Look
PremiumCompany Announcements
AbbVie’s Promising Phase 2 Study on ADPKD Treatment: A Closer Look
11h ago
ABBV
AbbVie’s Upadacitinib Study: A New Hope for Hidradenitis Suppurativa?
PremiumCompany Announcements
AbbVie’s Upadacitinib Study: A New Hope for Hidradenitis Suppurativa?
11h ago
ABBV
AbbVie’s Venetoclax Study Update: Long-Term Safety in Focus
PremiumCompany Announcements
AbbVie’s Venetoclax Study Update: Long-Term Safety in Focus
11h ago
ABBV
AbbVie’s Long-term Study on Bimatoprost SR: A Potential Game-Changer in Glaucoma Treatment
PremiumCompany Announcements
AbbVie’s Long-term Study on Bimatoprost SR: A Potential Game-Changer in Glaucoma Treatment
11h ago
ABBV
AbbVie’s Real-World Study on Crohn’s Disease Treatments: Market Implications
PremiumCompany AnnouncementsAbbVie’s Real-World Study on Crohn’s Disease Treatments: Market Implications
11h ago
ABBV
AbbVie’s New Study on Psoriatic Arthritis: What Investors Need to Know
Premium
Company Announcements
AbbVie’s New Study on Psoriatic Arthritis: What Investors Need to Know
1d ago
ABBV
AbbVie Advances Rheumatoid Arthritis Treatment with New Phase 2 Study
Premium
Company Announcements
AbbVie Advances Rheumatoid Arthritis Treatment with New Phase 2 Study
1d ago
ABBV
AbbVie’s New Study on CLL Treatments: Market Implications and Investor Insights
PremiumCompany Announcements
AbbVie’s New Study on CLL Treatments: Market Implications and Investor Insights
1d ago
ABBV
AbbVie’s Rinvoq Study in Japan: A Closer Look at Ulcerative Colitis Treatment
PremiumCompany Announcements
AbbVie’s Rinvoq Study in Japan: A Closer Look at Ulcerative Colitis Treatment
1d ago
ABBV
AbbVie’s Oriahnn Study: Evaluating Hair Loss in Women with Uterine Fibroids
PremiumCompany Announcements
AbbVie’s Oriahnn Study: Evaluating Hair Loss in Women with Uterine Fibroids
1d ago
ABBV
AbbVie’s Humira Study Completion: Implications for Pyoderma Gangrenosum Treatment
PremiumCompany Announcements
AbbVie’s Humira Study Completion: Implications for Pyoderma Gangrenosum Treatment
1d ago
ABBV
AbbVie’s New Study on Crohn’s Disease Therapies: A Potential Game Changer?
PremiumCompany AnnouncementsAbbVie’s New Study on Crohn’s Disease Therapies: A Potential Game Changer?
1d ago
ABBV
AbbVie’s Risankizumab Pregnancy Study: A Potential Game-Changer?
Premium
Company Announcements
AbbVie’s Risankizumab Pregnancy Study: A Potential Game-Changer?
1d ago
ABBV
AbbVie’s Ubrogepant Study: A New Hope for Menstrual Migraine Relief
Premium
Company Announcements
AbbVie’s Ubrogepant Study: A New Hope for Menstrual Migraine Relief
1d ago
ABBV

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >